The short answer
BI-RADS 5 is report language that needs context. In breast imaging reports, it means the imaging appearance is highly suspicious for cancer and usually needs prompt tissue diagnosis. This page explains the plain-language meaning, limits, likely next questions, and why your care team must interpret it with the rest of your results.
BI-RADS 5 has a specific meaning in breast imaging reports.
The phrase alone is not the whole diagnosis or treatment plan.
The next step depends on the full report, prior tests, symptoms, and your cancer history.
Ask what the finding changes, what remains uncertain, and when you will review the plan.
Choose how you want to understand this
The full explanation.
The number is a probability, and it is a high one
BI-RADS stands for Breast Imaging Reporting and Data System. It is the scoring scale radiologists use to close out a breast imaging report. Category 5 is labeled "highly suggestive of malignancy."
Behind that phrase is a figure. StatPearls puts the likelihood of cancer for a BI-RADS 5 finding at more than 95%. RadiologyInfo describes it as a 95% chance that breast cancer is present, with biopsy strongly recommended.
That is not a diagnosis. It is a prediction based on how the finding looks, and it is accurate enough that the whole system treats a 5 as a call to act quickly.
Where 5 sits on the scale
The full ladder, with the malignancy risks StatPearls and RadiologyInfo attach to the suspicious end:
- 0 — incomplete; more imaging is needed before a verdict
- 1 — negative
- 2 — benign finding, such as a cyst
- 3 — probably benign; risk below 2%; NCI notes a follow-up mammogram at 6 months
- 4A — 2% to 10% chance of cancer
- 4B — 10% to 50%
- 4C — 50% to 95%
- 5 — above 95%
- 6 — cancer already proven by biopsy
Notice that 5 and 6 are different. A 5 means the radiologist is confident from the images alone. A 6 means tissue has already confirmed it. If your report says 5, no tissue has been examined yet.
What the radiologist actually saw
Category 5 is not assigned to a vague shadow. It is assigned to specific patterns.
For masses, StatPearls describes the most concerning combination as an irregular shape with spiculated margins and high density. Spiculated means the edges send out fine lines into the surrounding tissue, like a starburst, instead of forming a smooth boundary.
For calcifications, which are tiny deposits of calcium, the worrying patterns are fine pleomorphic and fine linear branching. Pleomorphic means the specks vary in size and shape rather than looking uniform. Fine linear branching means they trace the inside of a duct.
Ask the radiologist or your doctor which of these words appear in your report. The descriptors carry more information than the number.
The next step is tissue, not another scan
NCI's own summary of the categories states it flatly: category 5 requires biopsy.
More imaging will not settle this. A repeat mammogram in six months is the pathway for a category 3, not a 5. If someone offers you short-interval follow-up for a BI-RADS 5, ask why the biopsy is being deferred.
Note also that a diagnostic mammogram is not the same study as a screening one. NCI explains that diagnostic mammography takes images from more angles, so the radiation dose is higher. Extra views are part of working the finding up, not a substitute for biopsy.
Concordance: the safety net nobody explains
Here is the part worth remembering. A biopsy of a BI-RADS 5 lesion that comes back benign does not end the story.
StatPearls describes this as discordance, meaning the pathology does not match what the imaging showed. When that happens, the recommendation is still surgical consultation, because the two findings conflict.
The logic is simple. A needle samples a narrow track. If the pictures say cancer is more than 95% likely and the needle says otherwise, the more likely explanation is that the needle missed.
So ask, out loud, at the results visit: is this biopsy result concordant with the imaging? Getting that question answered in writing is one of the highest-value things you can do.
The rest of the report still matters
Two other items in the same document affect your care.
Breast density. RadiologyInfo lists four categories: almost entirely fatty, scattered fibroglandular tissue, heterogeneously dense, and extremely dense. NCI notes that mammography is more likely to miss cancer in dense breasts. Density does not change the meaning of a 5, but it shapes how much you trust a clear result elsewhere in the breast.
The comparison. Ask whether prior mammograms were available for comparison, and whether the finding is new or changed. A new spiculated mass and a stable one are read differently.
Do not wait on these symptoms
Some breast cancers do not show as a mass at all. NCI's fact sheet on inflammatory breast cancer lists these signs, which come on rapidly:
- Skin that looks pink, reddish purple, or bruised
- Dimpling or ridges like the skin of an orange
- A breast that grows in size quickly
- Heaviness, burning, or tenderness
- A nipple that turns inward
- Swollen nodes under the arm or near the collarbone
NCI adds a warning that matters here: inflammatory breast cancer usually cannot be seen on a mammogram. A normal or reassuring image does not rule it out. These signs are often mistaken for mastitis, a breast infection. If you are treated with antibiotics and the skin changes do not clear promptly, go back and say so.
What to do in the next few days
- Confirm a biopsy is scheduled, and get the date before you leave or hang up
- If no date exists within a week of the report, call the breast imaging center directly
- Ask which biopsy type is planned, and whether a clip marker will be placed
- Ask when pathology results are expected and who will call you
- Bring any outside prior mammograms on a disc, so the radiologist can compare
Questions to ask
- What descriptors led to the 5, and were prior images available?
- Is a biopsy of the lymph nodes planned at the same time?
- Who reviews whether the pathology matches the imaging?
- Will hormone receptor and HER2 testing be run on this sample?
- What is the plan if the biopsy comes back benign?
Next on the breast imaging path
What Does BI-RADS Mean on a Mammogram Report? walks the whole scale. What Does BI-RADS 4 Mean? covers the tier below this one. Biopsy explains the procedure itself, and Pathology Reports covers what comes back.
Sources
Words to know
Tap any term to see what it means.

Common questions
What does BI-RADS 5 mean?
In general, BI-RADS 5 means the imaging appearance is highly suspicious for cancer and usually needs prompt tissue diagnosis.
Does it mean cancer?
It is still an imaging category; final diagnosis comes from pathology when tissue is sampled.
What should I ask next?
A practical next question is to ask about biopsy timing, who will explain the pathology results, and whether previous images or multidisciplinary review are needed.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Look up related pathology, imaging, biomarker, and treatment-response language.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 3 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-20 what this meansLast updated: 2026-08-06Next planned review: 2027-07-20
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
